Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer

Urology
Eun-Jung KimWun-Jae Kim

Abstract

To investigate the association between expression levels of topoisomerase-II alpha (TOP-2alpha) and prognosis in primary non-muscle-invasive bladder cancer (NMIBC). TOP-2alpha, a marker of cell proliferation, has been assessed as a prognostic indicator in several types of cancer. However, currently available data on the role of TOP-2alpha in prognosis are inconsistent. Top-2alpha messenger ribonucleic acid (mRNA) levels were examined in 103 tumor specimens from patients with primary NMIBC by real-time polymerase chain reaction. Immunohistochemical staining was performed on 39 matched tumor samples. The median follow-up period for all patients was 51.8 months (range, 3.2-137). The mRNA expression levels of TOP-2alpha were significantly elevated in subjects with high-grade (P<.001) and high-stage (P=.041) tumors as compared with subjects with low-grade and low-stage tumors. Kaplan-Meier estimates revealed significant variation in tumor recurrence and progression depending on the level of TOP-2alpha expression (log-rank test, P<.05). Multivariate Cox regression analysis revealed that the level of TOP-2alpha expression is a strong predictor of recurrence (hazard ratio, 2.507; 95% confidence interval, 1.228-5.116; P=.012) and progre...Continue Reading

References

Jan 1, 1989·Preparative Biochemistry·U Strausfeld, A Richter
Apr 18, 2001·Journal of Clinical Pathology·L NakopoulouC Dimopoulos
Apr 4, 2003·International Journal of Cancer. Journal International Du Cancer·Lúcio SantosCarlos Lopes
Feb 26, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shahrokh F ShariatSeth P Lerner
Mar 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James W F CattoFreddie C Hamdy
Apr 28, 2006·International Journal of Cancer. Journal International Du Cancer·Frank ChristophMark Schrader
Nov 13, 2007·The Journal of Urology·M Craig HallPaul F Schellhammer
Jul 22, 2008·The Journal of Urology·Eun-Jung KimWun-Jae Kim

❮ Previous
Next ❯

Citations

Feb 13, 2013·Journal of Translational Medicine·Marina França de ResendeRafael Malagoli Rocha
Mar 17, 2016·Investigative and Clinical Urology·Sung Kyu Hong
Mar 17, 2016·Investigative and Clinical Urology·Ye-Hwan KimWun-Jae Kim
Mar 16, 2013·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Kai TangLi-Ming Li
Mar 9, 2013·BJU International·Mårten LindénPer-Uno Malmström
Jun 27, 2015·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Xiao-Li XieHideki Wanibuchi
Oct 21, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yousaf Ali, Shafida Abd Hamid
Mar 15, 2014·Journal of Immunoassay & Immunochemistry·Soumaya Ben AbdelkrimMoncef Mokni
Oct 18, 2018·Current Urology Reports·William Tabayoyong, Ashish M Kamat
Oct 30, 2018·Frontiers in Oncology·Matteo GiuliettiFrancesco Piva
Aug 5, 2011·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.